Clinical trials sponsored by RenJi Hospital

Phase breakdown

Conditions studied

Recruiting trials led by RenJi Hospital

• A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
  NCT06249438 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• A Study of Initiation Timing of VTE Prevention After Colorectal Cancer Surgery
  NCT06259149 · Phase: Not specified · Ages: 18 Years to 110 Years · Sex: All (male and female) · 1 location
• A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa Patients
  NCT06469710 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: Male · 1 location
• Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women
  NCT03201861 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
  NCT04254263 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• COLORECTUM+ Digital System for Postoperative Quality Improvement in Colorectal Cancer
  NCT06685497 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial
  NCT05360290 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)
  NCT06458010 · Phase: Early Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Clinical Study of HIFU for Localized Prostate Cancer
  NCT06362577 · Phase: Not specified · Ages: 40 Years and older · Sex: Male · 1 location
• Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer
  NCT05910398 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer
  NCT06306612 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: Male · 1 location
• Dalpiciclib in HR+/HER2- ABC
  NCT06301438 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Disitamab Vedotin (RC48-ADC) in Breast Cancer
  NCT05851677 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients
  NCT05858684 · Phase: Early Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients
  NCT06394063 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer
  NCT06478225 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Feasibility Study of Diaphragm Synchronized Pacing (DSP) Via the Left Inferior Phrenic Vein (LIPV) Approach
  NCT07392749 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• ImmunoPET Imaging of Pancreatic Cancer
  NCT06602037 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Lecanemab for Early Onset Familial Alzheimer's Disease
  NCT06883019 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · 15 locations
• Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT)
  NCT07283692 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Obesity Queue Database
  NCT06391320 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Pre-operative Therapy in Breast Cancer
  NCT05621564 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location
• Prospective Observational Study on Comprehensive Effects of PEEK Cranioplasty and Titanium Cranioplasty After DC（RECEPT-DC）
  NCT05416684 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• RC48-ADC in HER2-low Advanced Breast Cancer
  NCT05831878 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment
  NCT05326399 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors
  NCT03392233 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Target-specific immunoPET Imaging of Digestive System Carcinoma
  NCT06715839 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• The Effects of Remimazolam on the Incidence of Severe Hypoxia During Sedated Hysteroscopy for Assisted Reproduction in Overweight or Obese Patients
  NCT06187896 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 50 Years · Sex: Female · 1 location
• Trop2-targeted immunoPET Imaging of Solid Tumors
  NCT06851663 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• miRNA Panel for PCa Diagnosis
  NCT07755592 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many trials is RenJi Hospital recruiting for?

RenJi Hospital is the lead sponsor of 30 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.